| 标题 |
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Heart Journal - Cardiovascular Pharmacotherapy 作者:Keith A A Fox; Victor Aboyans; E Sebastian Debus; Uwe Zeymer; Martin R Cowie; et al 出版日期:2022-05-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)